Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The provided content is consistent with the label excerpts for BIKTARVY regarding HBV testing, risk of severe acute hepatitis B exacerbation after discontinuation, and patient counseling not to discontinue without provider input.
Category Scores
Accurate Statements
Patients with HIV-1 should be tested for the presence of chronic HBV before or when initiating antiretroviral therapy.
5.1 and 2.1 (HBV testing prior to or when initiating BIKTARVY)
Severe acute exacerbations of hepatitis B have been reported in patients with HIV-1 and HBV who have discontinued products containing FTC and/or TDF, and may occur with discontinuation of BIKTARVY.
5.1
Patients with HIV-1 and HBV who discontinue BIKTARVY should be closely monitored with clinical and laboratory follow-up for at least several months after stopping treatment.
5.1
If appropriate, anti-hepatitis B therapy may be warranted, especially in patients with advanced liver disease or cirrhosis.
5.1
Severe acute exacerbations of hepatitis B have been reported in patients with HBV and HIV-1 who have discontinued products containing FTC and/or TDF, and may occur with discontinuation of BIKTARVY.
17 (Patient Counseling Information)
Advise the patient not to discontinue BIKTARVY without first informing their healthcare provider.
17
Unsupported Statements
Contradictions
Important Omissions
No full labeling evaluation was possible beyond the provided excerpts because no additional AI response claims were supplied for assessment (e.g., dosage specifics, contraindications, boxed warnings, drug interactions, adverse reactions, storage/handling).
Importance:
Low
Safety Assessment
Potential Patient Risk:
Low
The evaluated statements align with label warnings/precautions and patient counseling regarding HBV testing and post-discontinuation HBV exacerbation monitoring.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement